Clinical Trials Directory

Trials / Completed

CompletedNCT01184677

ProSeal Laryngeal Mask Airway (LMA) Size 3 vs 4 in Non-paralyzed Female Patients

Comparison of the Size 3 ProsealTM Laryngeal Mask Airway Versus Size 4 in Anaesthetized, Non-paralyzed Women: A Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that ProSeal laryngeal mask airway (PLMA) of smaller size would reduce the incidence of mucosal injury.

Detailed description

The ProSealTM laryngeal mask airway (PLMA; Laryngeal Mask Co. Limited, Mahe, Seychelles) is a laryngeal mask device with an added dorsal cuff to improve the seal and a drainage tube to prevent aspiration and gastric insufflations(Brain, Verghese et al. 2000).Despite its utility, there are complications associated with PLMA insertion such as sore throat and mucosal injury including oropharyngeal blood. The purpose of this randomized controlled study is to determine if size 3 PLMA would induce less mucosal damage indicated by blood on the cuff than size 4 in non-paralyzed female patients. The secondary objective of this study is to compare insertion time, number of attempts, oropharyngeal leak pressure, hemodynamic variables, and incidence of complications with size 3 and 4 PLMA.

Conditions

Interventions

TypeNameDescription
DEVICEinsertion of the ProSeal LMA (PLMA)ProSeal LMA size 3 is inserted to the patients of Group size 3.
DEVICEinsertion of the PLMAProSeal LMA size 4 is inserted to the patients of Group size 4.

Timeline

Start date
2010-08-01
Primary completion
2011-12-01
Completion
2012-02-01
First posted
2010-08-19
Last updated
2012-08-27

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01184677. Inclusion in this directory is not an endorsement.